Valanx Biotech Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $888K
Latest Deal Amount
  • Investors
  • 4

Valanx Biotech General Information

Description

Developer of a site-specific protein conjugation platform designed to develop fast and cost-efficient protein-drug-conjugates. The company's platform develops drugs that target only the cancer cells and solve the problem of tedious and ineffective protein conjugation, enabling healthcare providers to produce receptor proteins with site-specific chemical handles attached.

Contact Information

Website
www.valanx.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Plöcking 1
  • IST Park Building
  • Klosterneuburg, 3400
  • Austria

Valanx Biotech Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Valanx Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 31-Jan-2020 $888K 00000 Completed Generating Revenue
1. Accelerator/Incubator 10-May-2017 00000 00000 00.000 Completed Startup
To view Valanx Biotech’s complete valuation and funding history, request access »

Valanx Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a site-specific protein conjugation platform designed to develop fast and cost-efficient protein-drug-conju
Drug Discovery
Klosterneuburg, Austria
5 As of 2020
00000
000000000 00000

00000 00

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aut
0000 00000000
South San Francisco, CA
000 As of 0000
00000
000000 - 000 00000

00000

in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occa
000000000000000
San Diego, CA
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Valanx Biotech Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sutro Biopharma Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
00000 Formerly PE-Backed San Diego, CA 00 00000 00000000 00000
You’re viewing 2 of 2 competitors. Get the full list »

Valanx Biotech Executive Team (2)

Name Title Board Seat Contact Info
Michael Lukesch Ph.D Co-Founder & Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Valanx Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Valanx Biotech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
IST cube Venture Capital Minority 000 0000 000000 0
SOSV Venture Capital Minority 000 0000 000000 0
Tecnet Equity Venture Capital Minority 000 0000 000000 0
RebelBio Accelerator/Incubator Minority 000 0000 000000 0
To view Valanx Biotech’s complete investors history, request access »